{"admin":{"created":{"date":"2018-11-14","schema_version":"1.0"},"last_modified":{"date":"2024-12-11","schema_version":"2.1"}},"domains":[],"established":2007,"external_ids":[{"all":["501100020141"],"preferred":"501100020141","type":"fundref"},{"all":["grid.427855.9"],"preferred":"grid.427855.9","type":"grid"},{"all":["0000 0004 5995 751X"],"preferred":null,"type":"isni"},{"all":["Q30286596"],"preferred":null,"type":"wikidata"}],"id":"https://ror.org/003br8b23","links":[{"type":"website","value":"https://akebia.com/"}],"locations":[{"geonames_details":{"continent_code":"NA","continent_name":"North America","country_code":"US","country_name":"United States","country_subdivision_code":"MA","country_subdivision_name":"Massachusetts","lat":42.3751,"lng":-71.10561,"name":"Cambridge"},"geonames_id":4931972}],"names":[{"lang":null,"types":["ror_display","label"],"value":"Akebia Therapeutics (United States)"}],"relationships":[],"status":"active","types":["company","funder"]}